NASA Logo

NTRS

NTRS - NASA Technical Reports Server

Back to Results
Tissue Engineering Using Transfected Growth-Factor GenesA method of growing bioengineered tissues includes, as a major component, the use of mammalian cells that have been transfected with genes for secretion of regulator and growth-factor substances. In a typical application, one either seeds the cells onto an artificial matrix made of a synthetic or natural biocompatible material, or else one cultures the cells until they secrete a desired amount of an extracellular matrix. If such a bioengineered tissue construct is to be used for surgical replacement of injured tissue, then the cells should preferably be the patient s own cells or, if not, at least cells matched to the patient s cells according to a human-leucocyteantigen (HLA) test. The bioengineered tissue construct is typically implanted in the patient's injured natural tissue, wherein the growth-factor genes enhance metabolic functions that promote the in vitro development of functional tissue constructs and their integration with native tissues. If the matrix is biodegradable, then one of the results of metabolism could be absorption of the matrix and replacement of the matrix with tissue formed at least partly by the transfected cells. The method was developed for articular chondrocytes but can (at least in principle) be extended to a variety of cell types and biocompatible matrix materials, including ones that have been exploited in prior tissue-engineering methods. Examples of cell types include chondrocytes, hepatocytes, islet cells, nerve cells, muscle cells, other organ cells, bone- and cartilage-forming cells, epithelial and endothelial cells, connective- tissue stem cells, mesodermal stem cells, and cells of the liver and the pancreas. Cells can be obtained from cell-line cultures, biopsies, and tissue banks. Genes, molecules, or nucleic acids that secrete factors that influence the growth of cells, the production of extracellular matrix material, and other cell functions can be inserted in cells by any of a variety of standard transfection techniques.
Document ID
20110014731
Acquisition Source
Johnson Space Center
Document Type
Other - NASA Tech Brief
Authors
Madry, Henning
(Massachusetts Inst. of Tech. Cambridge, MA, United States)
Langer, Robert S.
(Massachusetts Inst. of Tech. Cambridge, MA, United States)
Freed, Lisa E.
(Massachusetts Inst. of Tech. Cambridge, MA, United States)
Trippel, Stephen
(Massachusetts Inst. of Tech. Cambridge, MA, United States)
Vunjak-Novakovic, Gordana
(Massachusetts Inst. of Tech. Cambridge, MA, United States)
Date Acquired
August 25, 2013
Publication Date
February 1, 2005
Publication Information
Publication: NASA Tech Briefs, February 2005
Subject Category
Man/System Technology And Life Support
Report/Patent Number
MSC-23352
Distribution Limits
Public
Copyright
Public Use Permitted.
No Preview Available